Search ( 33361 results )
- article
(Updated on )
Application of molecular biology to blood transfusion safety: genomic viral screening
Viral genomic screening (VGS) for HIV-1 and HCV was introduced in France on July 1, 2001, with the aim of enhancing transfusion safety by reducing the residual risk posed by the...
(Updated on )
Epidemiological surveillance of allogeneic blood donors in France between 2001 and 2003. National Surveillance of Infectious Diseases, 2001–2003
Key points: - Prevalence rates remained stable over the 2001–2003 period: 0.60 per 104 new donors for HIV, 8.0 per 104 for HCV, 1.8 per 104 for HBsAg, and 0.56 per 104 for HTLV. -...
- article
(Updated on )
Prevalence of hepatitis B and C viruses, HIV, and HTLV among candidates for scheduled autologous transfusions in France, 1993–2000
Epidemiological surveillance of candidates for autologous transfusion was established in France in 1993. The number of candidates increased steadily between 1993 and 1997 and then...
- article
(Updated on )
Changes in the residual risk of viral infection transmission through blood transfusion between 1992 and 2001 in France and the impact of DGV
This study analyzes trends in the residual risk of transmission of HIV, HBV, and HCV through blood transfusion over eight three-year periods from 1992 to 2001 and compares, for HIV and...
- article
(Updated on )
AIDS Surveillance in Europe, June 30, 1989. Screening of blood donations
- article
(Updated on )
Screening for markers of HIV, HTLV, and hepatitis B and C infections among blood donors in France
- article
(Updated on )
Results of HIV antibody screening at blood transfusion centers (BTCs) in 1987
- article
(Updated on )
HIV-2 and Blood Transfusion. Report by the "Retrovirus" Group of the Working Committee on Infections Transmitted by Blood Transfusion of the National Blood Transfusion Society (STNS)
- article
(Updated on )
Impact of Excluding Donors Who Have Stayed in the British Isles on the Residual Risk of HIV Transmission Through Transfusion of Labile Blood Products
Objective. Among the measures likely to reduce the risk of transmission of the agent causing the new variant of Creutzfeldt-Jakob disease, excluding blood donations from donors who had...
